Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Clinical Pharmacokinetics
|
May 13, 2017
Clinical Pharmacokinetics and Mass Balance of Veliparib in Combination with Temozolomide in Subjects with Nonhematologic Malignancies
Silpa Nuthalapati, Wijith Munasinghe, Vincent Giranda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 19, 2008
Phase 0 trials: an industry perspective
Helen Eliopoulos, Vincent Giranda, Robert Carr, et al.
Clinical Colorectal Cancer
|
June 28, 2024
Safety and Efficacy of Vicriviroc (MK-7690) in Combination With Pembrolizumab in Patients With Advanced or Metastatic Microsatellite Stable Colorectal Cancer
Alberto Bessudo, Abdul Mustajeeb Haseeb, James A Reeves, et al.
Cancer Chemotherapy and Pharmacology
|
October 5, 2015
A phase 1 study evaluating the pharmacokinetics and preliminary efficacy of veliparib (ABT-888) in combination with carboplatin/paclitaxel in Japanese subjects with non-small cell lung cancer (NSCLC)
Hidenori Mizugaki, Noboru Yamamoto, Hiroshi Nokihara, et al.
Journal of Neuro-Oncology
|
February 16, 2015
Veliparib in combination with whole brain radiation therapy in patients with brain metastases: results of a phase 1 study
Minesh P Mehta, Ding Wang, Fen Wang, et al.
Investigational New Drugs
|
May 20, 2024
Correction to: CXCR2 antagonist navarixin in combination with pembrolizumab in select advanced solid tumors: a phase 2 randomized trial
Andrew J Armstrong, Ravit Geva, Hyun Cheol Chung, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 3, 2016
Randomized, Placebo-Controlled, Phase II Study of Veliparib in Combination with Carboplatin and Paclitaxel for Advanced/Metastatic Non-Small Cell Lung Cancer
Suresh S Ramalingam, Normand Blais, Julien Mazieres, et al.
Neuro-Oncology
|
June 9, 2014
A phase I trial of veliparib (ABT-888) and temozolomide in children with recurrent CNS tumors: a pediatric brain tumor consortium report
Jack M Su, Patrick Thompson, Adekunle Adesina, et al.
Investigational New Drugs
|
February 7, 2024
CXCR2 antagonist navarixin in combination with pembrolizumab in select advanced solid tumors: a phase 2 randomized trial
Andrew J Armstrong, Ravit Geva, Hyun Cheol Chung, et al.
Neuro-Oncology
|
February 4, 2020
A phase I/II study of veliparib (ABT-888) with radiation and temozolomide in newly diagnosed diffuse pontine glioma: a Pediatric Brain Tumor Consortium study
Patricia A Baxter, Jack M Su, Arzu Onar-Thomas, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Clinical Pharmacokinetics
|
May 13, 2017
Clinical Pharmacokinetics and Mass Balance of Veliparib in Combination with Temozolomide in Subjects with Nonhematologic Malignancies
Silpa Nuthalapati, Wijith Munasinghe, Vincent Giranda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 19, 2008
Phase 0 trials: an industry perspective
Helen Eliopoulos, Vincent Giranda, Robert Carr, et al.
Clinical Colorectal Cancer
|
June 28, 2024
Safety and Efficacy of Vicriviroc (MK-7690) in Combination With Pembrolizumab in Patients With Advanced or Metastatic Microsatellite Stable Colorectal Cancer
Alberto Bessudo, Abdul Mustajeeb Haseeb, James A Reeves, et al.
Cancer Chemotherapy and Pharmacology
|
October 5, 2015
A phase 1 study evaluating the pharmacokinetics and preliminary efficacy of veliparib (ABT-888) in combination with carboplatin/paclitaxel in Japanese subjects with non-small cell lung cancer (NSCLC)
Hidenori Mizugaki, Noboru Yamamoto, Hiroshi Nokihara, et al.
Journal of Neuro-Oncology
|
February 16, 2015
Veliparib in combination with whole brain radiation therapy in patients with brain metastases: results of a phase 1 study
Minesh P Mehta, Ding Wang, Fen Wang, et al.
Investigational New Drugs
|
May 20, 2024
Correction to: CXCR2 antagonist navarixin in combination with pembrolizumab in select advanced solid tumors: a phase 2 randomized trial
Andrew J Armstrong, Ravit Geva, Hyun Cheol Chung, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 3, 2016
Randomized, Placebo-Controlled, Phase II Study of Veliparib in Combination with Carboplatin and Paclitaxel for Advanced/Metastatic Non-Small Cell Lung Cancer
Suresh S Ramalingam, Normand Blais, Julien Mazieres, et al.
Neuro-Oncology
|
June 9, 2014
A phase I trial of veliparib (ABT-888) and temozolomide in children with recurrent CNS tumors: a pediatric brain tumor consortium report
Jack M Su, Patrick Thompson, Adekunle Adesina, et al.
Investigational New Drugs
|
February 7, 2024
CXCR2 antagonist navarixin in combination with pembrolizumab in select advanced solid tumors: a phase 2 randomized trial
Andrew J Armstrong, Ravit Geva, Hyun Cheol Chung, et al.
Neuro-Oncology
|
February 4, 2020
A phase I/II study of veliparib (ABT-888) with radiation and temozolomide in newly diagnosed diffuse pontine glioma: a Pediatric Brain Tumor Consortium study
Patricia A Baxter, Jack M Su, Arzu Onar-Thomas, et al.
Page
of 2